This topic contains a solution. Click here to go to the answer

Author Question: A patient is experiencing status epilepticus. The nurse prepares to give which drug of choice for ... (Read 57 times)

Coya19@aol.com

  • Hero Member
  • *****
  • Posts: 601
A patient is experiencing status epilepticus. The nurse prepares to give which drug of choice for the treatment of this condition?
 
  a. Diazepam (Valium)
  b. Midazolam (Versed)
  c. Valproic acid (Depakote)
  d. Carbamazepine (Tegretol)

Question 2

The nurse is giving an intravenous dose of phenytoin (Dilantin). Which action is correct when administering this drug?
 
  a. Give the dose as a fast intravenous (IV) bolus.
  b. Mix the drug with normal saline, and give it as a slow IV push.
  c. Mix the drug with dextrose (D5W), and give it as a slow IV push.
  d. Mix the drug with any available solution as long as the administration rate is correct.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Galvarado142

  • Sr. Member
  • ****
  • Posts: 348
Answer to Question 1

ANS: A

Answer to Question 2

ANS: B




Coya19@aol.com

  • Member
  • Posts: 601
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


xiazhe

  • Member
  • Posts: 331
Reply 3 on: Yesterday
Excellent

 

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

Earwax has antimicrobial properties that reduce the viability of bacteria and fungus in the human ear.

Did you know?

Urine turns bright yellow if larger than normal amounts of certain substances are consumed; one of these substances is asparagus.

Did you know?

Bacteria have flourished on the earth for over three billion years. They were the first life forms on the planet.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library